Summary of this article
The Rs 250.8 crore fresh issue opens on December 22, 2025, with a price band of Rs 108 to Rs 114 per share.
Total income surged by 637 per cent in FY25 to Rs 40.4 crore, while net profit grew by 455 per cent year-on-year.
Proceeds will fund the acquisition of Parekh Hospital and Ashwini Medical Centre to scale its regional multispeciality healthcare network in Gujarat.
Gujarat Kidney & Super Speciality’s initial public offering (IPO) is set to open for subscription on December 22. The three-day subscription window will close on December 24. The hospital chain plans to raise Rs 250.8 crore through the public issue.
Here are some key details from the Red Herring Prospectus which primary market participants should know before the issue opens for subscription:
Gujarat Kidney & Super Speciality IPO: Offer Size and Price Band
Gujarat Kidney & Super Speciality’s issue size is Rs 250.8 crore IPO and consists of an issuance of 22 million new shares. The price band for Gujarat Kidney & Super Speciality IPO has been set between Rs 108 and Rs 114 per share. The minimum lot size to apply for the hospital chain operator’s public issue for the retail category has been set at 128 shares, indicating an investment of Rs 14,592.
Gujarat Kidney & Super Speciality IPO: Subscription Window, Allotment Date, Listing Date
Following the closure of the subscription window, the basis of allotment for Gujarat Kidney & Super Speciality IPO is expected to be determined on December 26. Successful applicants will receive the shares in their demat accounts on December 29. The Gujarat based company’s shares are expected to be listed on the BSE and NSE, with the listing tentatively scheduled for December 30.
Gujarat Kidney & Super Speciality IPO: Key Financials
For the quarter ended June 30, 2025, Gujarat Kidney & Super Speciality reported a total income of Rs 15.27 crore. The healthcare services provider’s profit after tax was Rs 5.40 crore, and its net worth stood at Rs 30.56 crore.
In the fiscal ended March 31, 2025, the healthcare services provider’s total income increased by more than 637 per cent to Rs 40.4 crore compared to Rs 5.48 crore in the preceding fiscal. The profit-after-tax of the Gujarat based company for FY 2024-25 grew by more than 455 per cent year-on-year to Rs was Rs 9.5 crore, compared to Rs 1.71 crore in the preceding fiscal.
Gujarat Kidney & Super Speciality: Business Model
Gujarat Kidney & Super Speciality is a regional healthcare provider based in Gujarat. The company manages a network of multispeciality hospitals and offers comprehensive healthcare services. The healthcare services provider operates seven multispeciality hospitals and four pharmacies in Gujarat.
Gujarat Kidney & Super Speciality: Competitors
The healthcare services industry is highly competitive, and the company faces competition from larger players as well as smaller, unorganised healthcare providers. Some of the listed competitors include Yatharth Hospital & Trauma Care Services, GPT Healthcare, and KMC Speciality Hospitals.
Gujarat Kidney & Super Speciality IPO: Should You Apply?
Before applying for the Gujarat based company’s public issue, investors should know these strengths and risks mentioned in the company’s RHP:
Gujarat Kidney & Super Speciality: Key Risks
Gujarat Kidney & Super Speciality’s RHP highlights several key risks related to its business:
The hospital chain operator mentioned that some of its offices and hospital premises are on leased property. Any issues related to the title or lease agreement can potentially disrupt operations.
The healthcare company generates a major part of its revenue via its hospital located in Vadodara. Since most of the hospitals are in central Gujarat, any changes in the economic or political conditions in or around Vadodara or central Gujarat could affect the company’s performance.
The company has reported losses in fiscal 2023. Sustaining such losses in the future could damage its reputation, business, and financial outcomes.
Gujarat Kidney & Super Speciality: Key Strengths
The company’s RHP outlines several key strengths:
The healthcare services provider claims that it is recognised for its expertise in renal sciences, with well-established sub-specialties in urology and strong capabilities in other medical fields.
The company claims that it runs hospitals that are well-suited in size, fully equipped, and located strategically, leading to a high return on investment.
The company mentioned in the RHP that it has attracted, trained, and retained skilled medical professionals.
Gujarat Kidney & Super Speciality IPO: Objective
The money raised via the public issue will be used for the acquisition of Parekh Hospital located in Ahmedabad and Ashwini Medical Centre. A portion of the funds will be allocated for capital expenditures and repaying certain outstanding secured loans. A part of the proceeds will also be utilised for acquisitions and general corporate purposes.
